RECURRENT PLASMA CELL MYELOMA
Clinical trials for RECURRENT PLASMA CELL MYELOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PLASMA CELL MYELOMA trials appear
Sign up with your email to follow new studies for RECURRENT PLASMA CELL MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising myeloma combo trial halted early – what we know
Disease control TerminatedThis study tested whether two drugs, daratumumab and pomalidomide, could help control multiple myeloma that came back after a stem cell transplant. It involved 13 adults whose cancer had relapsed. The goal was to see if the combination could lead to complete remission and delay t…
Matched conditions: RECURRENT PLASMA CELL MYELOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 22, 2026 12:06 UTC
-
Blood cancer transplant study tests safer GVHD prevention
Disease control TerminatedThis phase 2 trial tested two different drug combinations to prevent graft-versus-host disease (GVHD) in 150 people with blood cancers receiving a stem cell transplant from an unrelated donor. Both combinations used cyclosporine and sirolimus, plus either mycophenolate mofetil or…
Matched conditions: RECURRENT PLASMA CELL MYELOMA
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 22, 2026 11:56 UTC